Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Hyaluronic Acid vs Platelet-R-rich Plasma for Chronic Tendinopathy and Enthesopathy

Official title: Comparative Analysis of the Efficacy of Hyaluronic Acid and Platelet-Rich Plasma Injections in the Treatment of Chronic Tendinopathies and Enthesopathies: A Prospective, Randomized Comparative Study

Run by Ortonika Orthopedic Medical Clinic in Lublin · NCT07714811 · Data updated 2026-11-12

This study tests whether injections of hyaluronic acid or autologous platelet-rich plasma can help people with chronic tendon and enthesis problems in the elbow or Achilles area.

More Tendinopathy trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment80 (estimated)
SponsorOrtonika Orthopedic Medical Clinic in Lublin
Academic / other
Locations1 site (Lublin, Lublin Voivodeship)
StatusRecruiting
StartedJune 10, 2026
Main results expectedJune 2028
Study endsJune 2028
Registry record updatedJuly 20, 2026
Trial IDNCT07714811 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 with chronic tendinopathy or enthesopathy of the Achilles or medial elbow region for more than 3 months and with VAS pain ≥40 mm.

Probably not a fit

Patients with recent injections, prior surgery on the target tendon, active infection, autoimmune disease, pregnancy, or BMI ≥40 may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two injectable approaches for chronic tendinopathy and enthesopathy. Participants have long-standing symptoms (over 3 months) with moderate to severe pain and are between 18 and 65 years old. The interventions are outpatient injections of hyaluronic acid or autologous PRP, aiming to support tendon and enthesis regeneration while minimizing safety risks. The study focuses on the elbow (medial epicondylopathy) and Achilles tendon region and excludes recent injections, prior surgery for the target tendon, infections, pregnancy, autoimmune conditions, and BMI 40 or higher. Outcomes likely center on pain and function, with safety monitoring.

Why it matters

Potential benefit: If successful, patients could experience reduced pain and improved function with a minimally invasive treatment option.

How similar studies have gone: Prior studies in tendinopathy with regenerative injections have shown mixed but promising signals for both HA and PRP approaches.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chronic tendinopathy or enthesopathy of the Achilles tendon or tendon insertion in the elbow region (medial epicondylopathy, so-called golfer's elbow)
* Symptom duration exceeding 3 months
* Pain intensity of at least 40 millimeters (mm) on a 100-mm Visual Analog Scale (VAS)
* Age 18-65 years
* Signed written informed consent

Exclusion Criteria:

* Previous surgical treatment of the studied tendon or tendon insertion
* Prior injection of corticosteroids, platelet-rich plasma (PRP), or hyaluronic acid into the area being studied within 3 months before enrollment
* Active systemic or local infection at the planned injection site
* Systemic inflammatory or autoimmune disease involving the joints, including rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus
* Pregnancy or breastfeeding
* Body mass index (BMI) of 40 kilograms per square meter (kg/m²) or greater

Where it's running

  • Ortonika Orthopedic Medical Clinic in Lublin
    Lublin, Lublin Voivodeship, Poland
    Recruiting

Study contacts

  • Principal investigator: Tomasz Wnuk, MD, PhD — Ortonika Orthopedic Medical Clinic
  • Study coordinator: Tomasz Wnuk, MD, PhD
  • Email: tomashorto@gmail.com
  • Phone: +48 538 360 332

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.